Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,067,875
-$177,388 QoQ
Shares Held
44,347
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,288
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Cleef Asset Management,Inc holds $14,679,161 across 8 Drug Manufacturers - General names. PFE ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,838 | $4,276,346 | |
| 2 | LLY |
ELI LILLY & Co
|
2,762 | $3,312,825 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,933 | $2,432,890 | |
| 4 | ABBV |
AbbVie Inc.
|
7,570 | $1,904,914 | |
| 5 | PFE |
Pfizer Inc
This page
|
44,347 | $1,067,875 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,952 | $625,635 | |
| 7 | AMGN |
Amgen Inc
|
1,572 | $569,252 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,494 | $489,424 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,067,875 | 44,347 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,245,263 | 44,347 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,134,120 | 45,547 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,160,537 | 45,547 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,106,677 | 45,655 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,207,780 | 47,663 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,269,513 | 47,852 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,457,418 | 50,360 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,221,136 | 79,383 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,386,111 | 85,986 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,540,947 | 88,258 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,741,334 | 82,645 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,068,208 | 83,648 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,428,260 | 84,026 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,321,581 | 84,340 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,696,669 | 84,476 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,572,682 | 87,215 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,285,986 | 82,789 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,706,816 | 79,709 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,340,371 | 77,665 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,080,678 | 78,669 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,864,307 | 79,059 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,921,904 | 79,378 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $2,921,353 | 79,601 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,864,817 | 87,609 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $3,359,369 | 102,922 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||